Boehringer Ingelheim reaches more patients in 2024 and prepares new medicine launches

Boehringer Ingelheim today announced a continued rise in the number of patients it reached, 66 million in 2024, up 8.0% from the previous year. Development of its current product pipeline is well on track, as the company prepares multiple…
Read More...